Lazard Asset Management
APYX icon

Lazard Asset Management’s Apyx Medical APYX Stock Holding History

Lazard Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,292
Closed -$31K – 2297
2022
Q2 		$31K Sell
5,292
-478
-8% -$2.45K ﹤0.01% 1990
2022
Q1 		$37K Hold
5,770
– – ﹤0.01% 1884
2021
Q4 		$73K Buy
5,770
+478
+9% +$6.69K ﹤0.01% 1561
2021
Q3 		$73K Buy
5,292
+1,677
+46% +$17.6K ﹤0.01% 1512
2021
Q2 		$37K Buy
+3,615
New +$35.8K ﹤0.01% 1708

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

Lazard Asset Management's APYX Position: Q3 2022 in Review

Lazard Asset Management sold out of Apyx Medical (APYX) in Q3 2022, closing a stake of 5,292 shares — an estimated $31K sold.

Lazard Asset Management first reported a position in APYX in Q2 2021 and held it in 5 quarters. The position peaked at $73K in Q4 2021. 54 funds tracked by Wall St. Rank hold APYX as of Q3 2022.

  • Lazard Asset Management reported no remaining Apyx Medical position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 5,292 Apyx Medical shares in Q3 2022, an estimated $31K.
  • Lazard Asset Management first reported a position in Apyx Medical in Q2 2021 and held it in 5 quarters.
  • Lazard Asset Management's Apyx Medical position peaked at $73K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.